CORRESP Filing
MEDICINOVA INC
Date: Sept. 26, 2025 · CIK: 0001226616 · Accession: 0001193125-25-220448
AI Filing Summary & Sentiment
File numbers found in text: 333-289801
Show Raw Text
CORRESP 1 filename1.htm CORRESP September 26, 2025 VIA EDGAR Division of Corporation Finance Office of Life Science United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell Re: Acceleration Request of MediciNova, Inc. Registration Statement on Form S-1 Filed August 22, 2025 (File No. 333-289801) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Tuesday, September 30, 2025, or as soon thereafter as practicable. The Registrant hereby authorizes Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration. Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060. Very truly yours, /s/ Yuichi Iwaki Yuichi Iwaki President and Chief Executive Officer